Alesia Tietze | Medicinal Chemistry in Cancer | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Alesia Tietze
Affiliation Department of Chemistry and Molecular Biology
Country Sweden
Scopus ID 55193803000
Documents 40
Citations 784
h-index 17
Subject Area Medicinal Chemistry in Cancer
Event Global Genetics Awards
ORCID 0000-0002-9281-548X

Alesia Tietze
Department of Chemistry and Molecular Biology

Alesia Tietze is a researcher affiliated with the Department of Chemistry and Molecular Biology in Sweden, with a research profile identified in the supplied academic information as relating to medicinal chemistry in cancer. The profile is associated with 40 Scopus-indexed documents, 784 citations, and an h-index of 17. These bibliometric indicators provide a quantitative view of research visibility and scholarly impact, while the award assessment itself should be based on the complete research record and independently verified evidence. [3]

Abstract

The Innovative Research Award profile for Alesia Tietze documents a research career represented in the supplied data by an affiliation with the Department of Chemistry and Molecular Biology in Sweden and a subject area of medicinal chemistry in cancer. The associated Scopus record is reported as containing 40 documents, 784 citations, and an h-index of 17. [1] These metrics can be used as supporting indicators of scholarly activity and citation reach, but they do not independently establish the novelty, methodological quality, translational significance, or originality of individual research contributions. The researcher is also associated with an ORCID identifier, providing a persistent identifier for distinguishing the scholarly record. [2]

Keywords

Alesia Tietze; Innovative Research Award; medicinal chemistry; cancer research; chemistry and molecular biology; cancer therapeutics; molecular research; research impact; Scopus; ORCID; Genetics Awards.

Introduction

Medicinal chemistry occupies an interdisciplinary position between chemistry, molecular biology, pharmacology, and therapeutic development. Research in this area may involve the design, synthesis, characterization, optimization, and biological evaluation of compounds intended to address disease-associated molecular targets. In cancer research, medicinal chemistry can intersect with studies of molecular mechanisms, therapeutic targets, biomarkers, drug resistance, and precision-oriented treatment strategies.

Within this broad research environment, academic recognition generally requires consideration of both quantitative and qualitative evidence. Bibliometric indicators such as document counts, citation counts, and h-index values can provide useful measures of scholarly visibility, while publications, methodological contributions, collaborations, and demonstrable scientific outcomes provide additional context. The Genetics Awards program states that submitted research profiles may undergo screening, credential verification, cross-checking of submitted information, and committee review before selection. [3]

Research Profile

The supplied profile identifies Alesia Tietze with the Department of Chemistry and Molecular Biology in Sweden and assigns the subject area of medicinal chemistry in cancer. The reported Scopus information comprises 40 documents, 784 citations, and an h-index of 17. [1] Taken together, these values indicate a documented body of indexed scholarly output and citation activity.

The research profile should be interpreted in relation to the underlying publications rather than as a standalone ranking. Citation indicators can vary according to database coverage, publication type, disciplinary citation practices, author disambiguation, and the date on which the record is consulted. The ORCID identifier supplied for the researcher offers an additional mechanism for connecting scholarly outputs to a persistent researcher identity. [2]

Research Contributions

Based on the supplied subject classification, Tietze’s academic profile is situated within medicinal chemistry in cancer. This field encompasses research that connects chemical science with biological and therapeutic questions relevant to oncology. The precise contribution of an individual researcher should, however, be established from verified publications, research projects, patents, datasets, collaborations, and other primary scholarly evidence rather than inferred solely from a subject-area label.

For an award evaluation, relevant evidence may include the originality of research questions, rigor of experimental or computational methods, reproducibility, significance of findings, contribution to interdisciplinary research, and potential relevance to cancer biology or therapeutic development. The Genetics Awards program identifies research excellence and related scientific contributions among the areas considered within its award framework. [3]

Publications

The supplied Scopus record reports 40 documents associated with the researcher. [1] Because individual publication titles, journals, publication years, authorship positions, and DOI identifiers were not supplied in the source information for this profile, specific publications are not enumerated here. This avoids attributing research findings or bibliographic details that have not been independently established.

For formal award documentation, the publication record can be verified through the researcher’s Scopus author profile and persistent ORCID identifier. Where individual publications are evaluated, DOI metadata should be checked against the publisher or DOI registration record before being included in a nomination dossier.

Research Impact

The supplied bibliometric indicators provide a measurable representation of scholarly impact: 784 citations across 40 reported documents and an h-index of 17. [1] These indicators may support an assessment of sustained research visibility, but they should be interpreted alongside publication quality, contribution to the scientific literature, collaboration, methodological innovation, and the broader significance of the research.

In the context of cancer-focused medicinal chemistry, research impact may also be considered through the extent to which scientific findings contribute to understanding disease mechanisms, identifying therapeutic opportunities, improving molecular tools, or informing subsequent research. Such outcomes require evidence from the underlying scholarly record and should not be inferred solely from citation statistics.

Award Suitability

The supplied profile presents several elements relevant to consideration for an Innovative Research Award: a defined research affiliation, a subject-area focus in medicinal chemistry and cancer, an established indexed publication record, and measurable citation activity. The reported h-index of 17 and 784 citations may serve as supporting bibliometric evidence of scholarly reach. [1]

Final award suitability should remain dependent on the official evaluation process and verification of the nominee’s complete research record. The Genetics Awards program describes a process involving submission screening, verification of credentials, cross-checking of information, committee review, and subsequent selection. [3] Accordingly, the present article should be understood as an academic recognition profile based on the supplied information rather than as an independent declaration of award selection.

Conclusion

Alesia Tietze’s supplied academic profile represents a researcher associated with the Department of Chemistry and Molecular Biology in Sweden and with medicinal chemistry in cancer. The reported Scopus indicators of 40 documents, 784 citations, and an h-index of 17 provide quantitative evidence of an established scholarly record. [1] The associated ORCID identifier further supports persistent scholarly identification. [2]

For the purposes of the Innovative Research Award, these indicators constitute useful supporting evidence but should be considered together with the originality, rigor, significance, and documented outcomes of the researcher’s work. A complete assessment should rely on verified publications and other primary academic evidence in accordance with the award’s stated evaluation procedures. [3]

References

  1. Elsevier. (n.d.). Scopus author details: Alesia Tietze, Author ID 55193803000.

    Scopus.https://www.scopus.com/authid/detail.uri?authorId=55193803000

  2. ORCID. (n.d.). ORCID record: Alesia Tietze, ORCID iD 0000-0002-9281-548X.
    https://orcid.org/0000-0002-9281-548X

  3. Targeted sortase A inhibition by novel peptidomimetic antivirulents against staphylococcal infections

    https://pubmed.ncbi.nlm.nih.gov/41773879/

  4. DNA Scission by Non-Histidine Amino-Terminal Cu(II) and Ni(II) Binding-Like Peptides

    https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cbic.70397

Stephanie Tuminello | Genetic Epidemiology | Innovative Research Award

Published on by Global Genetics Award

 

Innovative Research Award

Stephanie Tuminello
Icahn School of Medicine at Mount Sinai

Stephanie Tuminello
Affiliation Icahn School of Medicine at Mount Sinai
Country United States
Scopus ID 57193871243
Documents 60
Citations 1,069
h-index 15
Subject Area Genetic Epidemiology
Event Global Genetics Awards

Stephanie Tuminello is affiliated with the Icahn School of Medicine at Mount Sinai, where her scholarly work contributes to the advancement of genetic epidemiology and related biomedical research. Her publication record, citation performance, and sustained research activity demonstrate continued engagement in understanding genetic determinants of disease, epidemiological methodologies, and translational biomedical science. Bibliometric indicators from Scopus show a substantial scholarly contribution supported by peer-reviewed publications and academic citations, reflecting the influence of her research within the international scientific community.[1]

Abstract

Stephanie Tuminello’s research portfolio focuses on genetic epidemiology through the integration of population-based investigation, molecular genetics, and clinical data analysis. Her scientific work contributes to understanding disease susceptibility, inherited genetic variation, and risk prediction using evidence-based epidemiological methodologies. The body of published literature demonstrates interdisciplinary collaboration and continued scientific productivity across multiple areas of biomedical research.[1]

Keywords

Genetic Epidemiology; Population Genetics; Human Genetics; Disease Susceptibility; Precision Medicine; Genomic Medicine; Epidemiological Research; Translational Medicine.

Introduction

Genetic epidemiology combines principles from genetics, epidemiology, and biostatistics to evaluate inherited and environmental influences on disease occurrence. Researchers working within this discipline investigate genetic risk factors, gene-environment interactions, and population-level disease patterns to improve healthcare outcomes. Stephanie Tuminello’s scholarly activities align with these objectives through peer-reviewed research that contributes to the broader understanding of genetic determinants of human health.[2]

Research Profile

According to publicly available bibliometric information, Stephanie Tuminello has authored 60 indexed publications that have collectively received more than one thousand citations, resulting in an h-index of 15. These indicators suggest sustained scholarly productivity and measurable research influence within biomedical sciences and genetic epidemiology.[1]

  • Affiliation: Icahn School of Medicine at Mount Sinai
  • Primary discipline: Genetic Epidemiology
  • Scopus-indexed publications: 60
  • Scopus citations: 1,069
  • Scopus h-index: 15

Research Contributions

The available publication record indicates contributions involving genetic risk assessment, epidemiological analysis, disease association studies, clinical research methodologies, and collaborative biomedical investigations. Such work supports improved understanding of disease mechanisms and facilitates evidence generation for future precision medicine initiatives.[1][3]

  • Population-based genetic investigations.
  • Clinical and translational epidemiological research.
  • Genetic susceptibility and disease association studies.
  • Interdisciplinary collaboration across biomedical sciences.

Publications

The author’s publication portfolio consists of peer-reviewed journal articles indexed by major scholarly databases. These publications collectively address topics within genetics, epidemiology, biomedical science, and translational research, demonstrating continued scientific productivity over multiple years.[1]

  • Research articles indexed in Scopus.
  • Collaborative multidisciplinary publications.
  • Biomedical and genetic epidemiology studies.

Research Impact

Bibliometric evidence indicates measurable academic influence through citations, publication output, and scholarly visibility. Citation metrics suggest that the published work has contributed to ongoing scientific discussions and has been referenced by researchers working in related biomedical disciplines. Such indicators are commonly employed in evaluating scientific productivity and research influence.[1]

Award Suitability

Stephanie Tuminello demonstrates characteristics generally considered during evaluation for an Innovative Research Award, including sustained publication activity, measurable citation impact, interdisciplinary collaboration, and contributions to genetic epidemiology. Recognition within an academic awards program would appropriately acknowledge continued scientific engagement while reflecting objective scholarly indicators rather than subjective assessments of scientific merit alone.[1]

Conclusion

Stephanie Tuminello has established an active academic profile through contributions to genetic epidemiology, peer-reviewed publications, and collaborative biomedical research. Publicly available bibliometric indicators demonstrate sustained scholarly productivity and research visibility, supporting recognition within academic and professional award programs dedicated to scientific excellence and innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Stephanie Tuminello, Author ID 57193871243.
    Scopus.https://www.scopus.com/authid/detail.uri?authorId=57193871243
  2. Disparities in COVID-19 testing and positivity in New York City
    https://www.sciencedirect.com/science/article/pii/S0749379720302634
  3. Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
    https://www.nature.com/articles/ncomms14922
  4. Male sex, severe obesity, older age, and chronic kidney disease are associated with COVID-19 severity and mortality in New York City
    https://journal.chestnet.org/article/S0012-3692(20)34288-4/fulltext
  5. The impact of asthma on mortality in patients with COVID-19
    https://journal.chestnet.org/article/S0012-3692(20)31645-7/fulltext

 

 Andrea Manica | Population genetics software | Innovative Research Award

Published on by Global Genetics Award

Innovative Research Award

Andrea Manica
Affiliation University of Cambridge
Country United Kingdom
Scopus ID 6603416293
Documents 187
Citations 17,182
h-index 67
Subject Area Population genetics software
Event Global Genetics Awards
ORCID 0000-0003-1895-450X

 Andrea Manica

University of Cambridge, United Kingdom

The Innovative Research Award recognizes sustained scholarly excellence and significant contributions to scientific advancement. Andrea Manica, a researcher at the University of Cambridge, has established an internationally recognized research profile in evolutionary biology, population genetics, human migration, ecological modelling, and computational approaches to biodiversity research. His scholarly publications, extensive citation record, and interdisciplinary collaborations demonstrate continued influence across genetics and evolutionary sciences.[1]

Abstract

Andrea Manica’s research integrates population genetics, ecology, anthropology, computational biology, and evolutionary theory to investigate biological diversity and human evolutionary history. His work combines large-scale genomic datasets, ecological modelling, and statistical methods to improve understanding of species distributions, migration processes, adaptation, and conservation. His scholarly achievements have resulted in a substantial international research profile with extensive citations and broad interdisciplinary impact.[1][2]

Keywords

Population genetics, evolutionary biology, ecological modelling, biodiversity, human migration, computational biology, conservation genetics, statistical ecology, genomics, species distribution modelling.

Introduction

Modern genetics increasingly relies upon interdisciplinary analytical approaches capable of integrating molecular, ecological, and computational evidence. Andrea Manica’s research exemplifies this trend by combining quantitative analysis with evolutionary theory to address questions concerning biodiversity, adaptation, and demographic history. His work has contributed to both methodological development and biological discovery while supporting evidence-based conservation research.[2]

Research Profile

Andrea Manica is affiliated with the University of Cambridge and maintains an internationally visible publication record indexed in Scopus. His documented scholarly metrics include 187 indexed publications, over 17,000 citations, and an h-index of 67, reflecting consistent scientific influence across multiple research disciplines.[1]

  • Population genetics and demographic inference.
  • Human evolutionary history.
  • Ecological and environmental modelling.
  • Biodiversity and conservation science.
  • Statistical and computational biology.

Research Contributions

His investigations have improved scientific understanding of how evolutionary processes, environmental factors, and migration shape genetic diversity. By integrating computational simulations with empirical observations, his studies have informed research concerning adaptation, population structure, climate influences, and conservation planning.[2][3]

  • Development of computational approaches for population genetics.
  • Analysis of human migration and demographic history.
  • Research supporting biodiversity conservation.
  • Integration of ecological and genomic datasets.
  • Interdisciplinary collaboration across genetics and ecology.

Publications

Andrea Manica has authored numerous peer-reviewed publications appearing in internationally recognized scientific journals. His research articles are frequently cited within genetics, ecology, anthropology, conservation biology, and evolutionary science, reflecting sustained scholarly relevance.[1]

  • Population genetic analyses.
  • Evolutionary modelling studies.
  • Human demographic history research.
  • Biodiversity conservation publications.

Research Impact

The documented citation metrics indicate extensive international recognition of Andrea Manica’s scholarly work. His publications continue to support research across genetics, ecology, anthropology, and environmental sciences while influencing computational methodologies and conservation strategies. The breadth of citations reflects continued relevance across diverse scientific communities.[1]

Award Suitability

Based on publicly available scholarly indicators, Andrea Manica demonstrates characteristics consistent with recognition through an Innovative Research Award. These include a sustained publication record, internationally recognized citation impact, interdisciplinary scientific contributions, methodological innovation, and continued advancement of population genetics and evolutionary biology research. Such accomplishments align with common evaluation criteria used in academic recognition programs.[1]

Conclusion

Andrea Manica’s scholarly career reflects substantial contributions to population genetics, computational biology, biodiversity research, and evolutionary science. Through interdisciplinary collaboration and quantitative innovation, his work has strengthened scientific understanding of biological diversity and evolutionary processes. His documented academic achievements support recognition within international research award programs dedicated to scientific excellence and innovation.[2]

References

    1. Elsevier. (n.d.). Scopus author details: Andrea Manica, Author ID 6603416293. Scopus.https://www.scopus.com/authid/detail.uri?authorId=6603416293
    2. ORCID. (n.d.). Andrea Manica
      ORCID Profile.      https://orcid.org/0000-0003-1895-450X
    3. Manica, A., et al. Representative research publication. Nature.
      DOI:
      https://doi.org/10.1038/nature06258
    4. Elsevier. (n.d.). Google scholar details: Andrea Manica.
      Google scholar. https://scholar.google.com/citations?user=v8V058QAAAAJ&hl=en
    5. An African origin for the intimate association between humans and Helicobacter pylori
       https://www.nature.com/articles/nature05562

Rui Xiao | Molecular Genetics | Editorial Board Member

Published on by Global Genetics Award

Prof. Rui Xiao | Molecular Genetics | Editorial Board Member

Inner Mongolia Medical University | China

Rui Xiao is a Professor and Director of the Key Laboratory of Molecular Pathology at Inner Mongolia Medical University, China. With a Ph.D. in Animal Biotechnology from Konkuk University, South Korea, he has built a distinguished academic career focusing on gene functions and molecular mechanisms of major diseases. He has led over 30 funded research projects and published more than 100 scientific papers, along with contributing to books and holding multiple patents. Professor Xiao actively serves in several scientific societies and as an expert reviewer for national programs. His contributions have earned him numerous awards and recognitions, highlighting his impact in biomedical research and education.

Citation Metrics (Scopus)

300
200
100
10
0

Citations
165

Documents
23

h-index
6

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile

Featured Publications

Abdul Karim Khalid | Host Genetics | Best Paper Award

Published on by Global Genetics Award

Mr. Abdul Karim Khalid | Host Genetics | Best Paper Award

Huazhong Agricultural University | China

Abdul Karim Khalid is a veterinary researcher specializing in preventive veterinary medicine, microbial pathogenesis, and host–microbe interactions, currently based in Wuhan, China. He earned his Master’s degree in Preventive Veterinary Medicine from Huazhong Agricultural University with a strong academic record, where his thesis focused on elucidating the role of the secreted protein MbovP537 as a virulence factor and diagnostic antigen in Mycoplasma bovis pathogenesis. His research integrates molecular microbiology, immunology, and translational One Health approaches, encompassing gene cloning, protein expression, mammalian cell culture, and advanced immunological assays. Abdul has contributed to multiple high-impact peer-reviewed publications in journals such as Veterinary Microbiology, eLife, Cells, and Frontiers in Immunology. He also holds a Doctor of Veterinary Medicine degree from Gomal University, Pakistan, and brings valuable clinical experience alongside strong bioinformatics and statistical analysis skills.

Citation Metrics (Scopus)

30
20
10
5
0

Citations
6

Documents
3

h-index
2

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile
 View GoogleScholar Profile

Junsong Yang | Genetics and Gnomics | Research Excellence Award

Published on by Global Genetics Award

Prof. Junsong Yang | Genetics and Gnomics | Research Excellence Award

Bengbu Medical University | China

Prof. Junsong Yang, Ph.D., is a Professor at Bengbu Medical University (BBMU), Bengbu, Anhui, China, with nearly two decades of academic and professional service at the institution. He earned his bachelor’s degree in Chemical Process Engineering from East China University of Science and Technology, followed by a Master of Science in Chemistry from the University of Science and Technology of China. He completed his doctoral degree in Chemistry at Anhui University. Over the past eighteen years at BBMU, Professor Yang has been actively engaged in teaching and research, with a strong focus on food quality and safety, contributing to the advancement of applied chemical sciences and public health-oriented education.

Citation Metrics (Scopus)

200
150
100
50
0

Citations
86

Documents
26

h-index
6

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Patrick Van Dijck | Host Genetics | Research Excellence Award

Published on by Global Genetics Award

Prof. Patrick Van Dijck | Host Genetics | Research Excellence Award

KU Leuven | Belgium

Prof. Patrick Van Dijck is a distinguished Professor at the Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Belgium, where he is internationally recognized for his pioneering research in infectious diseases and host genetics. His work has made significant contributions to understanding human fungal pathogens, particularly the molecular and cellular mechanisms that govern host–pathogen interactions and fungal virulence. Through innovative experimental approaches and interdisciplinary collaboration, Prof. Van Dijck has advanced the field of molecular microbiology and improved insights relevant to the prevention and treatment of fungal infections. In recognition of his outstanding scientific achievements, global impact, and sustained excellence in research, he has been honored with the prestigious Research Excellence Award.

Citation Metrics (Scopus)

15000
10000
5000
500
0

Citations
14,475

Documents
257

h-index
67

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile
 View Google Scholar Profile

Featured Publications

Sreevarsha Gali Venkatesulu| Cancer Genetics | Women Researcher Award

Published on by Global Genetics Award

 Dr. Sreevarsha Gali Venkatesulu | Cancer Genetics | Women Researcher Award

Sungkyunkwan university | South Korea

Dr. Sreevarsha Gali Venkatesulu is an accomplished researcher in Cancer Genetics whose innovative contributions to understanding genetic drivers of tumor progression, hereditary cancer risk, and molecular mechanisms of oncogenesis have earned her recognition as a leading woman scientist in the field. Her work integrates advanced genomics, biomarker discovery, and precision oncology approaches to improve early cancer detection and personalize therapeutic strategies. Through her impactful publications, collaborative research initiatives, and dedication to advancing women’s representation in scientific research, Dr. Venkatesulu has significantly strengthened the global landscape of cancer genetics. Her exceptional academic achievements, translational research efforts, and commitment to scientific excellence make her a distinguished recipient of the Women Research Award in Cancer Genetics.

Profiles: Scopus | Google Scholar | Orcid

Featured Publications

"a Selective Histone Deacetylase 6 Inhibitor, Suppresses Triple-Negative Breast Cancer Cells via AKT/mTOR Pathway", Gali, S.; Sharma, S.; Noh, H.; Kim, I.S.; Kim, H.S. BKS-112., 2025

"An experimental and computational exploration on synthesis, structural elucidation, weaker interaction and anticancer activity analysis of novel progesterone oxadiazole derivative",Prakash, Poonam R, Gali S, Manish K, C, Anant R, Shipra G, Amul D, Anupama, P, R.N. Singh, Kim Hyung Sik., 2025

"Therapeutic potential of bark extracts from Macaranga denticulata on renal fibrosis in streptozotocin-induced diabetic rats", Gali, S.; Kundu, A.; Sharma, S.; Ahn, M. Y.; Puia, Z.; Kumar, V. Kim, H. S., 2025

"a Selective SIRT1/2 Inhibitor, Attenuates High-fat Diet-induced Hepatic Fibrosis via Inhibition of HSC Activation in ZDF Rats",Fengfeng Xiao; Yongkang Liu; Sharma S, Gali, S, Kundu A, Park JH, Kim JS, Kim HS., 2025

Dongli Pan | Herpesvirus Infection | Best Researcher Award

Published on by Global Genetics Award

Prof. Dr. Dongli Pan | Herpesvirus Infection | Best Researcher Award

Zhejiang University School of Medicine | China

Dr. Prof. Dongli Pan is a distinguished biochemist whose research has significantly advanced the understanding of viral pathogenesis and host-virus interactions. She earned her Ph.D. in Biochemistry from the University of Pennsylvania, Philadelphia (2001–2007), where her dissertation focused on the fast kinetics of tRNA movement on the ribosome during bacterial translation elongation, following a B.S. in Chemistry from Peking University, Beijing (1997–2001). Currently a Professor at the Zhejiang University School of Medicine, Dr. Pan’s major research interests center on the mechanisms of herpes simplex virus (HSV) infection and pathogenesis, HSV-host interactions, and anti-HSV drug development. Her research excellence has been recognized through several competitive national grants, including major projects funded by the National Key R&D Project of China and the National Natural Science Foundation of China, with total funding exceeding several million RMB. Dr. Pan has led and contributed to groundbreaking studies on viral latency, host microRNAs, and innate immune responses to DNA viruses. Before joining Zhejiang University, she conducted postdoctoral research at Harvard Medical School and the University of Pennsylvania, deepening her expertise in molecular virology. In addition to her research, Dr. Pan is a dedicated educator, actively involved in undergraduate and graduate teaching at Zhejiang University and the Zhejiang University–University of Edinburgh Institute, where she organizes and lectures in courses such as Infection 3, Pathogens, and Medical Microbiology and Parasitology, fostering the next generation of biomedical scientists through her bilingual instruction and mentorship.

Profiles: Scopus

Featured Publications

"Inhibitory effect of Alantolactone against varicella-zoster virus in vitro", Virology JournalThis link is disabled., 2025.

"A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing",Nature CommunicationsThis link is disabled., 2025.

"Discovery of Novel Piperazinone-Fused Hydroxypyridinones Inhibiting Herpes Simplex Virus Gene Transcription and Viral Replication", Journal of Medicinal Chemistry, 2025.

"Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells", J. Virol, 2025.

Kang Yang | Metabolic Disorders | Best Researcher Award

Published on by Global Genetics Award

Dr. Kang Yang | Metabolic Disorders | Best Researcher Award

Northern Jiangsu People's Hospital affiliated with Yangzhou University | China

Author Profile

Scopus

Orcid Id

EARLY ACADEMIC PURSUITS 🎓

Kang Yang embarked on his academic journey at Shandong First Medical University, where he pursued a Bachelor of Medicine (BM) in 2017 under the mentorship of Professor Jianhong Qi. His early interest in sports medicine and rehabilitation laid a strong foundation for his future contributions in the field.

Building on this, he further honed his expertise at Yangzhou University, obtaining a Master of Medicine (MM) in 2020 under the guidance of Professor Xianghe Chen. His postgraduate studies deepened his understanding of rehabilitation techniques, patient care, and innovative treatments in sports medicine.

PROFESSIONAL ENDEAVORS 💼

As a rehabilitation physician and therapist, Kang Yang is committed to enhancing the quality of life for patients recovering from injuries, surgeries, and physical impairments. His work integrates advanced rehabilitation methodologies with patient-centered approaches to ensure effective recovery and functional restoration.

Throughout his career, he has actively contributed to both clinical practice and academic research, focusing on rehabilitation strategies tailored for athletes and individuals with musculoskeletal disorders.

CONTRIBUTIONS AND RESEARCH FOCUS ON METABOLIC DISORDERS🔬

Kang Yang’s research primarily revolves around sports medicine and rehabilitation medicine. His investigations explore:

  • Innovative rehabilitation techniques for sports-related injuries.
  • Physiological and biomechanical adaptations in long-distance runners and athletes.
  • Post-injury recovery protocols aimed at optimizing healing and preventing re-injury.

His dedication to research has led to significant advancements in sports rehabilitation, with a particular focus on marathon runners and endurance athletes.

IMPACT AND INFLUENCE 🔍

Kang Yang's contributions extend beyond clinical settings. His work has influenced:

  • Rehabilitation strategies for sports professionals.
  • Medical education, through his involvement in teaching and mentoring young medical students.
  • Public awareness on the importance of injury prevention and rehabilitation in sports.

His clinical expertise and research have helped shape modern rehabilitation protocols, making a positive impact on both patient outcomes and medical practices.

ACADEMIC CITATIONS AND RECOGNITION 🏆

Kang Yang’s academic excellence has been recognized through multiple prestigious awards:

  • Special Prize (2018) & First Prize (2019) at the Jiangsu Sports Graduate Innovation Forum.
  • 2019 National Scholarship for Postgraduates (China).
  • First-class academic scholarship from Yangzhou University.

These accolades highlight his commitment to academic excellence, research innovation, and contributions to the medical community.

LEGACY AND FUTURE CONTRIBUTIONS🏰

Looking ahead, Kang Yang aims to:

  • Expand his research on sports rehabilitation and injury prevention.
  • Develop advanced therapeutic protocols for athletes and individuals recovering from physical trauma.
  • Collaborate with international experts to enhance rehabilitation medicine globally.
  • Continue mentoring students and young professionals in the field of rehabilitation sciences.

His unwavering passion and dedication position him as a future leader in the evolving landscape of sports medicine and rehabilitation.

BEYOND MEDICINE: PERSONAL INTERESTS 📚

Outside of his professional life, Kang Yang enjoys:

  • Long-distance running and marathons, reflecting his deep understanding of sports medicine from both a theoretical and practical perspective.
  • Reading, staying updated with the latest medical advancements and broadening his intellectual horizons.

NOTABLE PUBLICATIONS📑

"Exercise alleviates renal interstitial fibrosis by ameliorating the Sirt1-mediated TGF-β1/Smad3 pathway in T2DM mice" 

  • Authors: X., Chen, Xianghe , X., Zeng, Xinyu , X., Qiu, Xiao , X., Zhou, Xiangxiang , K., Yang, Kang
  • Journal: Endocrine Connections
  • Year: 2024